Join
Live feed
·
INSIDERFilingvia Quantisnow
UroGen Pharma Ltd. logo

Director Robinson James A. Jr. converted options into 2,000 units of ordinary shares, increasing direct ownership by 33% to 8,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
URGN· UroGen Pharma Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track URGN (UroGen Pharma Ltd.) and more on Quantisnow.